During the past decade, Guy's Hospital; Louise Coote Lupus Unit conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Guy's Hospital; Louise Coote Lupus Unit" are "Systemic Lupus Erythematosus" (2 trials) and "Lupus Erythematosus, Systemic" (1 trials). Many other conditions were trialed in "Guy's Hospital; Louise Coote Lupus Unit" in a lesser frequency.

Most popular intervention types in "Guy's Hospital; Louise Coote Lupus Unit" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "GDC-0853" (2 trials), "Placebo" (2 trials), "Acetaminophen/Paracetamol" (1 trials), "Diphenhydramine hydrochloride" (1 trials) and "Methylprednisolone" (1 trials). Other intervention names were less common.

The vast majority of trials in "Guy's Hospital; Louise Coote Lupus Unit" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Guy's Hospital; Louise Coote Lupus Unit". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Guy's Hospital; Louise Coote Lupus Unit, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Guy's Hospital; Louise Coote Lupus Unit, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".